ArticleJournal of inflammation research2025
Efficacy Analysis of a 12-Cytokine Panel for the Diagnosis of Kawasaki Disease and Prediction of Intravenous Immunoglobulin Resistance.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- FOS regulation of T-cell activation and the mechanism of inflammatory injury of coronary endothelium in Kawasaki disease.Translational pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the diagnostic and predictive value of a 12-cytokine panel for Kawasaki disease (KD) and intravenous immunoglobulin (IVIG) resistance. Patients and Methods: A retrospective case-control study was conducted using clinical data from children diagnosed with KD at Children's Hospital, Zhejiang University School of Medicine, between December 1, 2023, and March 30, 2025. Demographic characteristics, laboratory findings, and echocardiographic results were collected. KD patients were compared with febrile controls without KD. Differences in sex, age, 12-cytokine profile, complete blood count, C-reactive protein level, and erythrocyte sedimentation rate were analyzed. Additionally, cytokine levels were compared between IVIG-resistant and IVIG-responsive KD patients to assess their predictive value for IVIG resistance. Results: A total of 686 KD patients and 101 febrile non-KD controls were enrolled. Compared with controls, KD patients were significantly younger and presented higher levels of IFN-α, IL-10, IL-1β, IL-2, IL-4, IL-5, IL-6, and IL-8, as well as elevated neutrophil counts and white blood cell counts. Logistic regression analysis identified age (in months), IL-10, IL-5, and the absolute neutrophil count as independent predictors of KD diagnosis. Among the KD patients, 80 were IVIG resistant. Compared with IVIG-responsive patients, IVIG-resistant patients presented significantly higher levels of IFN-γ, IL-10, IL-17, IL-2, IL-5, IL-6, and IL-8 but lower levels of IFN-α. Logistic regression revealed that IL-10 and IL-8 were independent predictors of IVIG resistance. When the concentration of IL-10 exceeded 14.70 pg/mL, the sensitivity and specificity for predicting IVIG resistance were 0.675 and 0.748, respectively. Similarly, when the concentration of IL-8 exceeded 23.55 pg/mL, the sensitivity and specificity were 0.725 and 0.658, respectively. Conclusion: The 12-cytokine panel has potential as a diagnostic and predictive tool for KD. Elevated IL-10 and IL-5 levels are independent predictors of KD diagnosis, whereas elevated IL-10 and IL-8 levels are independent predictors of IVIG resistance. These findings support the clinical utility of cytokine profiling in KD management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.